logo
welcome
torontosun

torontosun

Ontario funding new treatment for advanced stage prostate cancer

torontosun
Summary
Nutrition label

69% Informative

Pluvicto is a targeted radioligand therapy, a radioactive drug that kills the specific cancer cells and uses a medical isotope that is produced in Ontario .

Health Canada approved the treatment in August 2022 , but patients have been waiting since then for coverage.

Ontario is the first jurisdiction to publicly fund and administer the treatment.

VR Score

66

Informative language

64

Neutral language

76

Article tone

semi-formal

Language

English

Language complexity

70

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links